Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

KWALITY PHARMACEUTICALS LTD.

NSE : NABSE : 539997ISIN CODE : INE552U01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE1431.2069.2 (+5.08 %)

PREV CLOSE ( ) 1362.00

OPEN PRICE ( ) 1388.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 182350

TODAY'S LOW / HIGH ( )1321.10 1456.00

52 WK LOW / HIGH ( ) 596.051456

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

1234.4

1110.51

1114.79

1156.76

Total Expenditure

934.89

856.97

873.02

897.9

PBIDT (Excl OI)

299.51

253.54

241.77

258.86

Other Income

5.28

8.97

3.76

7.65

Operating Profit

304.78

262.51

245.53

266.52

Interest

24.82

28.42

27.6

24.92

Exceptional Items

-8.29

PBDT

271.67

234.09

217.93

241.6

Depreciation

48.22

49.6

47.65

50.86

Profit Before Tax

223.45

184.49

170.28

190.74

Tax

63.46

43.35

51.08

45.94

Provisions and contingencies

Profit After Tax

159.99

141.14

119.2

144.8

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

159.99

141.14

119.2

144.8

Minority Interest

0.09

0.00

0.06

0.09

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

160.09

141.16

119.26

144.89

Equity Capital

103.76

Face Value (IN RS)

Reserves

Calculated EPS

15.42

13.60

11.49

13.96

Calculated EPS (Annualised)

61.71

54.41

45.97

55.85

No of Public Share Holdings

4687176

4687226

% of Public Share Holdings

45.17

PBIDTM% (Excl OI)

24.26

22.83

21.68

22.37

PBIDTM%

24.69

23.63

22.02

23.04

PBDTM%

22.00

21.07

19.54

20.88

PBTM%

18.10

16.61

15.27

16.48

PATM%

12.96

12.70

10.69

12.51

Notes

Risk Disclosures on Derivatives

Quarterly Results

KWALITY PHARMACEUTICALS LTD.